Document Detail


Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine.
MedLine Citation:
PMID:  15939309     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Regular use of inhaled beta2-agonists might lead to tolerance as reflected in a loss of bronchoprotection. In vitro-data suggest that this might be prevented by disodium cromoglycate (DSCG). Therefore, we studied the effect of the beta2-agonist reproterol in combination with DSCG. In a cross-over design, 19 subjects with airway hyperresponsiveness inhaled either placebo, 1mg reproterol, 2 mg DSCG, or 1mg reproterol plus 2 mg DSCG 4x daily over 2 weeks. Treatment periods were separated by > or = 7 days. Before and at the end of periods, lung function and methacholine responsiveness were determined in the morning, and 6h later the bronchodilator effect and the protection against methacholine-induced bronchoconstriction. Reproterol or DSCG or their combination did not exert detrimental effects on lung function, airway responsiveness, or bronchodilator capacity. However, bronchoprotection was significantly reduced (p < 0.05) after treatment with placebo, reproterol or reproterol plus DSCG, the respective changes being 0.59, 0.96 and 1.37 doubling concentrations. All changes were small as compared to intraindividual variability. In this model all treatments except with DSCG caused a significant but small loss of protection against methacholine-induced bronchoconstriction. Thus, tolerance was not prevented by 2 weeks of additional treatment with DSCG, in contrast to in vitro findings.
Authors:
Frank Kanniess; Rudolf A Jörres; Helgo Magnussen
Related Documents :
22134469 - Physical exercise in young patients with congenital heart disease.
2828449 - Mechanisms of acute increases in airway responsiveness caused by environmental chemicals.
8335859 - The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstrictio...
19191129 - Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asth...
823849 - An assessment of the pulmonary response to exercise in asthma and an analysis of the fa...
1546839 - Comparison of bronchial reactivity and peak expiratory flow variability measurements fo...
2583149 - The effects of substrate utilization, manipulated by caffeine, on post-exercise oxygen ...
1555429 - Supply-dependent oxygen consumption and mixed venous oxyhemoglobin saturation during is...
12527979 - Effects of pre-exercise ingestion of carbohydrate on glycaemic and insulinaemic respons...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial     Date:  2005-04-25
Journal Detail:
Title:  Pulmonary pharmacology & therapeutics     Volume:  18     ISSN:  1094-5539     ISO Abbreviation:  Pulm Pharmacol Ther     Publication Date:  2005  
Date Detail:
Created Date:  2005-06-07     Completed Date:  2005-09-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9715279     Medline TA:  Pulm Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  315-20     Citation Subset:  IM    
Affiliation:
Pulmonary Research Institute Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, D-22927 Grosshansdorf, Germany. f.kanniess@pulmoresearch.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Adolescent
Adult
Bronchial Hyperreactivity / chemically induced,  prevention & control*
Bronchial Provocation Tests
Bronchoconstrictor Agents / diagnostic use*
Bronchodilator Agents / administration & dosage,  pharmacology,  therapeutic use*
Cromolyn Sodium / administration & dosage,  pharmacology,  therapeutic use*
Cross-Over Studies
Double-Blind Method
Drug Combinations
Drug Therapy, Combination
Female
Humans
Male
Methacholine Chloride / diagnostic use*
Middle Aged
Orciprenaline / administration & dosage,  analogs & derivatives*,  pharmacology,  therapeutic use
Theophylline / administration & dosage,  analogs & derivatives*,  pharmacology,  therapeutic use
Chemical
Reg. No./Substance:
0/Bronchoconstrictor Agents; 0/Bronchodilator Agents; 0/Drug Combinations; 15826-37-6/Cromolyn Sodium; 54063-54-6/reproterol; 58-55-9/Theophylline; 586-06-1/Orciprenaline; 62-51-1/Methacholine Chloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Time reduction and process optimization of the baculovirus expression system for more efficient reco...
Next Document:  The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in th...